Google

Provings

 

Dominici G., Allegri F., Andreotti M. C., Calieri R., Mariani I., Pomposelli R., Tonini E., Lanza L.

STREPTOCOCCINUM

STREPTOCOCCINUM
Proving 2012 conducted by the School of Homeopathy, Verona

The Streptococcinum nosode is a homeopathic remedy produced from two strains of Streptococcus pyogenes Rosenbach, Mercy n. 433, 434. The School of Homeopathy in Verona conducted the proving of Streptococcinum between February and May 2012. The participants were recruited from students and teachers at the school: 16 provers, 6 supervisors, 1 coordinator and 1 director. The proving consisted of a triple blind test with a 25% placebo control sample. 30c (4), 200c (4) and MK (4) potencies were used together with placebo control samples (4). The observation period lasted 30 days. The provers were consulted at regular intervals to assess the persistence of the symptoms for up to 12 months after the start of the proving. The pathogenesis and symptomatology is particularly interesting. Under experimental conditions, it seems to reproduce certain pathologies caused by Streptococcus pyogenes such as scarlet fever and rheumatism. The digestive system was particularly affected. Proving has been confirmed to be a reliable experimental method and a source of important information both for the substance being ‘proved’ and the intensity and duration of action of the homeopathic remedy.  
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

G. Dominici, F. Allegri, M. C. Andreotti, M. Impallomeni, C. Marcolin, I. Mariani, E.Tonini, R. Pomposelli

PROVING OF COLIBACILLINUM

PROVING OF COLIBACILLINUM
Homeopathic School of Verona 2011

 Colibacillinum is a relatively unknown nosode. The Homeopathic School of Verona organized a proving of the homeopathic drug which was conducted between February and May 2011. The subjects were recruited from students and teachers of the school: 15 provers, 6 supervisors, 1 coordinator and 1 director. The proving consisted of a triple blind test with a 20% placebo control sample. 30CH (6), 200CH (3) and MK (3) potencies were used together with a placebo (3). The observation period lasted 30 days. The article describes the symptoms experienced (pathogenesis). The results show that  Colibacillinum can be prescribed as a homeopathic medicine.


- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

HOMEOPATHY (2006) 95, 123-130
G. Dominici, P. Bellavite, C. di Stanislao, P. Gulia, G. Pitari

DOUBLE-BLIND, PLACEBO-CONTROLLED HOMEOPATHIC PATHOGENETIC TRIALS: SYMPTOM COLLECTION AND ANALYSIS

DOUBLE-BLIND, PLACEBO-CONTROLLED HOMEOPATHIC PATHOGENETIC TRIALS: SYMPTOM COLLECTION AND ANALYSIS

Homeopathic pathogenetic trials (provings) are fundamental to homeopathy. Since most of the data from available provings have not been statistically evaluated, it is unclear how specific reported symptoms are and how they differ from those reported by people taking placebo. Method: We combine and analyse data from two different homeopathic pathogenic trials—including 10 and 11 provers, respectively, and both including 30% placebo—to test the null hypothesis that there is no significant difference between the number of symptoms in placebo and verum groups. Results: The principal results were: _ Placebo reported less symptoms than verum groups. _ Symptom distribution according to predefined classes (common symptoms increased in intensity and/or duration-, cured, old, new and exceptional) was statistically different between placebo and verum group at a high level of significance (Po0.001). Compared to verum, placebo provers reported less new and old but more common (increased in duration or intensity) symptoms. _ Within repertory categories, other differences were detected. _ The two groups differ in terms of the duration of each symptom and kinetics of symptoms: most symptoms were more persistent in verum than in placebo groups and verum provers recorded a decreasing number of symptoms with time. Placebo provers did not show such a temporal pattern. Conclusions: If confirmed by other studies these results would demonstrate the non equivalence between homeopathic medicines in high dilution and placebo and contribute to the improvement of proving methodology and evaluation.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

1 2

© 2008 VESCOVIO Center Homeopathy. All Rights Reserved.